You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology
Atopic Dermatitis as a Risk Factor for the Development of Food Allergies
In this video from the 2024 Society for Pediatric Dermatology Symposium held in Toronto, Canada, Dr. Peter Leo, MD discusses the role of atopic dermatitis as a risk factor for developing food allergies.
MD
Peter Lio
Learning objectives
Explore how atopic dermatitis can be a risk factor for the development of food allergies and other atopic comorbidities
MAT-US-2502949 v1.0 – P Expiration Date: 12/16/2026
About this expert
Dermatology
Peter Lio
MD
Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai, NY; Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, Illinois, US
ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.
For healthcare professionals in Algeria: Please read the additional Terms of Use.
All rights reserved. MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025
All Rights Reserved.
Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.